Patents by Inventor David Rosen

David Rosen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8995344
    Abstract: A wireless network access device comprising a radio interface with a serial communication line, a switch, and M serial connections to M connectors for connecting up to M corresponding detachable radio modules. The radio interface forms up to M individually addressable radio communications paths. Each radio module includes a radio configured to communicate with client devices in a coverage area and a radio processor configured to manage at least one radio receiving buffer. The radio receiving buffers store receiver buffer identifiers to corresponding received data space. A processor manages communication between the client devices that communicate with the radio modules and a data network via the radio interface and a network interface when N?M radio modules are connected to the radio interface. An assist engine is connected in the serial connection between the processor and the switch to manage allocation of receive buffer identifiers to the radio modules.
    Type: Grant
    Filed: October 8, 2012
    Date of Patent: March 31, 2015
    Assignee: Xirrus, Inc.
    Inventors: Drew Bertagna, David Rosen
  • Publication number: 20140155379
    Abstract: Compounds and methods in the fields of chemistry and medicine are disclosed. Some of the disclosed embodiments include compounds, compositions and methods of using heterocycle amines. Some of the disclosed embodiments include heterocycle amines useful to treat inflammatory disorders.
    Type: Application
    Filed: December 20, 2013
    Publication date: June 5, 2014
    Applicant: Ligand Pharmaceuticals Incorporated
    Inventors: Koc-Kan Ho, David Diller, Jeffrey J. Letourneau, Brian F. McGuinness, Andrew G. Cole, David Rosen, Cornelis A. van Oeveren, Jason C. Pickens, Lin Zhi, Yixing Shen, Bijan Pedram
  • Patent number: 8426558
    Abstract: The present invention is a peptide compound which stimulates the formation of hard tissues such as bone and cartilage. The invention is also related to a method to treat a defect in hard tissues such as bone and cartilage using the peptide. The method of the present invention may be used to treat or prevent the defects in bones and cartilages which are caused by rheumatoid arthritis or osteoarthritis which involves the regeneration of new bone or cartilage in or around the defects.
    Type: Grant
    Filed: December 15, 2010
    Date of Patent: April 23, 2013
    Assignee: OrthoTrophix, Inc.
    Inventors: Catherine Middleton-Hardie, Mirella Lazarov, David Rosen
  • Publication number: 20130089031
    Abstract: A wireless network access device comprising a radio interface with a serial communication line, a switch, and M serial connections to M connectors for connecting up to M corresponding detachable radio modules. The radio interface forms up to M individually addressable radio communications paths. Each radio module includes a radio configured to communicate with client devices in a coverage area and a radio processor configured to manage at least one radio receiving buffer. The radio receiving buffers store receiver buffer identifiers to corresponding received data space. A processor manages communication between the client devices that communicate with the radio modules and a data network via the radio interface and a network interface when N <M radio modules are connected to the radio interface. An assist engine is connected in the serial connection between the processor and the switch to manage allocation of receive buffer identifiers to the radio modules.
    Type: Application
    Filed: October 8, 2012
    Publication date: April 11, 2013
    Applicant: Xirrus, Inc.
    Inventors: Drew Bertagna, David Rosen
  • Publication number: 20130071271
    Abstract: A valveless, pulsatile, non-contact, positive displacement, finger-pump for pumping one or more fluids is disclosed. The pump can include one or more channels for holding one or more lengths of flexible tubing. The channels can include an adjustment mechanism and/or a resilient backing plate to reduce over compression of the tubing. The pump can utilize a plurality of profiled, pivoting fingers to sequentially occlude a length of tubing causing a pumping action. The fingers can be moved from the first position to the second position by a motor driven camshaft. Cam lobes disposed on the camshaft can be a modified eccentric design to improve tube occlusion and pump efficiency. At least one cam lobe can completely occlude the tubing at all times during operation to prevent backflow. The fingers can alternatively be moved from the first position to the second position by a variety of linear actuators.
    Type: Application
    Filed: March 17, 2011
    Publication date: March 21, 2013
    Inventors: David Rosen, David Ku, Jane Kang
  • Publication number: 20120276558
    Abstract: As disclosed herein, the present invention provides for kits and a composition for diagnosis, prognosis, drug discovery, drug development, and patient stratification. The kits can comprise a plurality of binding elements for cell surface markers, and a plurality of binding elements for state-specific intracellular markers. The kits can further comprise a plurality of modulators directed for the particular cell function or signaling pathways. The kits can further include fixatives, permeabilizing agent, buffers, containers, instructions, and software for data analysis/compilation.
    Type: Application
    Filed: July 9, 2012
    Publication date: November 1, 2012
    Applicant: Nodality, Inc.
    Inventors: David Soper, David Rosen, Todd Covey, Ying-Wen Huang, Wenday Fantl, Ralph Lin
  • Patent number: 8242248
    Abstract: As disclosed herein, the present invention provides for kits and a composition for diagnosis, prognosis, drug discovery, drug development, and patient stratification. The kits can comprise a plurality of binding elements for cell surface markers, and a plurality of binding elements for state-specific intracellular markers. The kits can further comprise a plurality of modulators directed for the particular cell function or signaling pathways. The kits can further include fixatives, permeabilizing agent, buffers, containers, instructions, and software for data analysis/compilation.
    Type: Grant
    Filed: March 23, 2010
    Date of Patent: August 14, 2012
    Assignee: Nodality, Inc.
    Inventors: David Soper, David Rosen, Ying-Wen Huang, Wendy Fantl
  • Publication number: 20120157340
    Abstract: The present invention provides methods, compositions and kits for the characterization of cellular pathways in cells containing genetic alterations.
    Type: Application
    Filed: June 9, 2011
    Publication date: June 21, 2012
    Inventors: Alessandra Cesano, Wendy J. Fantl, David Rosen
  • Publication number: 20120121558
    Abstract: The disclosure of the present application provides compositions and methods for treating a blood disorder. In at least one embodiment of a method for treating a patient with a plasma protein deficiency disorder, the method comprises the steps of administering a cell-based composition to a patient with a plasma protein deficiency disorder to treat the plasma protein deficiency disorder, where the cell-based composition comprises a mammalian adipose stromal cell that is capable of effectuating the production of a plasma protein within the patient.
    Type: Application
    Filed: May 17, 2011
    Publication date: May 17, 2012
    Inventors: Keith Leonard March, Elliot David Rosen, Katherine Marcucci, Katherine High
  • Patent number: 8119563
    Abstract: N-substituted azacycle derivative compounds represented by formula (I): wherein m, q, r, t and u are independently selected from 0 or 1; and p is 0, 1, 2, or 3; and A, B, D, X, Y, R, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10 and R11 are fully described herein. The compounds being particularly useful in compositions comprising an insecticidally effective amount of at least one compound of formula I, and an insecticidally compatible carrier are also disclosed; along with methods of controlling insects comprising applying said compositions to a locus where insects are present or are expected to be present.
    Type: Grant
    Filed: October 4, 2004
    Date of Patent: February 21, 2012
    Assignee: FMC Corporation
    Inventors: George Theodoridis, David Rosen, Shunxiang Zhang, Walter H. Yeager, Robert N. Henrie, II, Syed Z. Ahmed, Hongbin Men, Stephen Donovan
  • Publication number: 20110251124
    Abstract: A method is disclosed whereby levels of calcium, phosphate and parathyroid hormone are measured in a patient. The patient is treated with a formulation comprising a compound having phosphotonin activity and thereafter measurements are made again. Dosing of the formulation is adjusted based on measurements with measuring, administering and adjusting dosing continually repeated as needed.
    Type: Application
    Filed: December 14, 2010
    Publication date: October 13, 2011
    Inventors: Thomas Haberberger, David Rosen, Yoshinari Kumagai
  • Publication number: 20110105401
    Abstract: The present invention is a peptide compound which stimulates the formation of hard tissues such as bone and cartilage. The invention is also related to a method to treat a defect in hard tissues such as bone and cartilage using the peptide. The method of the present invention may be used to treat or prevent the defects in bones and cartilages which are caused by rheumatoid arthritis or osteoarthritis which involves the regeneration of new bone or cartilage in or around the defects.
    Type: Application
    Filed: December 15, 2010
    Publication date: May 5, 2011
    Inventors: CATHERINE MIDDLETON-HARDIE, Mirella Lazarov, David Rosen
  • Patent number: 7888462
    Abstract: The present invention is a peptide compound which stimulates the formation of hard tissues such as bone and cartilage. The invention is also related to a method to treat a defect in hard tissues such as bone and cartilage using the peptide. The method of the present invention may be used to treat or prevent the defects in bones and cartilages which are caused by rheumatoid arthritis or osteoarthritis which involves the regeneration of new bone or cartilage in or around the defects.
    Type: Grant
    Filed: January 22, 2008
    Date of Patent: February 15, 2011
    Assignee: Acologix, Inc.
    Inventors: Catherine Middleton-Hardie, Mirella Lazarov, David Rosen
  • Publication number: 20110009991
    Abstract: Digitally distributing media content using a distribution backbone system, including: receiving a request for media content from a client, the request including a client profile; performing inventory and analysis of source assets by iteratively progressing through the client profile to create output; performing a capability mapping in which a series of rules that allow the source assets to be mapped to the client profile; and planning a manufacturing process, which determines work items and execution steps from capabilities mapped in response to the request for media content from the client.
    Type: Application
    Filed: June 11, 2010
    Publication date: January 13, 2011
    Applicants: SONY CORPORATION, SONY PICTURES ENTERTAINMENT INC.
    Inventors: Rick Dinicola, David Rosen, Ryan Kido, Tatsuya Oiye, Keith Stevens
  • Patent number: 7860594
    Abstract: The present invention provides a method for making an ophthalmic device. In particular, the present invention provides a method for production of a contact lens by means of stereolithography. A preferred stereolithography technique is based on polymerization and solidification of a contact lens forming liquid material by actinic irradiation one layer at a time. In addition, the present invention provides systems and methods for making a contact lens for a specific patient based on the prescription.
    Type: Grant
    Filed: April 17, 2007
    Date of Patent: December 28, 2010
    Assignee: Novartis AG
    Inventors: Rafael Victor Andino, Robert Scott Meece, David Rosen, Benay Sager
  • Publication number: 20100240542
    Abstract: As disclosed herein, the present invention provides for kits and a composition for diagnosis, prognosis, drug discovery, drug development, and patient stratification. The kits can comprise a plurality of binding elements for cell surface markers, and a plurality of binding elements for state-specific intracellular markers. The kits can further comprise a plurality of modulators directed for the particular cell function or signaling pathways. The kits can further include fixatives, permeabilizing agent, buffers, containers, instructions, and software for data analysis/compilation.
    Type: Application
    Filed: March 23, 2010
    Publication date: September 23, 2010
    Applicant: Nodality, Inc.
    Inventors: David Soper, David Rosen, Todd Covey, Ying-Wen Huang, Wendy Fantl, Ralph Lin
  • Publication number: 20100105074
    Abstract: The invention provides systems, compositions, kits and methods for automated processing of biological samples and analysis using a flow cytometer.
    Type: Application
    Filed: October 27, 2009
    Publication date: April 29, 2010
    Applicant: Nodality, Inc. a Delaware Corporation
    Inventors: Todd Covey, Adam Palazzo, Norman Purvis, James Cordiero, David Rosen
  • Publication number: 20100099109
    Abstract: The present invention provides methods, instruments, reagents, kits and the biology involved in analyzing drug response. An embodiment of the present invention provides an approach for the characterization a plurality of pathways in single cells. This approach permits the rapid detection of heterogeneity in a complex cell population based on activation states of cellular molecules such as proteins, expression markers and other criteria, and the identification of cellular subsets that exhibit correlated changes in activation within the cell population. Some of these categories include redox potential, ITIM phosphorylation, intracellular pH and other categories allows for characterization of such pathways and cell populations. Also, the present analysis is useful for the analysis of the effect of compounds on potential target cells.
    Type: Application
    Filed: October 19, 2009
    Publication date: April 22, 2010
    Inventors: Wendy J. Fantl, David Rosen
  • Patent number: 7685231
    Abstract: A method and system are herein disclosed for registering a member at a targeted web-based information management system using a reduced amount of member and system interaction to confirm and establish the member's contact information. Generally, the method may communicate permission to solicit a potential member to the information management system. In one embodiment, the member previously communicated permission to receive solicitations from other systems to another web-based information management system. The method may communicate the permission from another web-based system to the present system. The permission may include member identification and/or demographic data. The method may communicate a solicitation message from the system to the member, the solicitation message comprising at least a portion of the member identification data.
    Type: Grant
    Filed: April 4, 2007
    Date of Patent: March 23, 2010
    Assignee: Mypoints.com Inc.
    Inventors: James John Bohannon, Andre Burgoyne, David Rosen
  • Patent number: 7638486
    Abstract: Formulations and methods to promote biological processes to form or regenerate new hard tissues such as bones, cartilage, and/or dental tissues are disclosed. The formulation comprising two proteins is administered to enhance biological activities of a hard tissue growth and differentiation factor characterized by specific and selective upregulation and/or extension of the retention time of the intracellular enzymes and signaling molecules that play important roles to proliferate, differentiate, maturate, and/or mineralize the hard tissue forming cells.
    Type: Grant
    Filed: July 12, 2006
    Date of Patent: December 29, 2009
    Assignee: Acologix, Inc.
    Inventors: Mirella Lazarov, Catherine Middleton-Hardie, David Rosen